A novel peptide and drug delivery system developed by a trio of Johns Hopkins researchers is close to improving vision care for millions of people who suffer from degenerative retinal diseases, such as wet age-related macular degeneration (AMD), diabetic macular edema, and diabetic retinopathy. On the eighth floor of the Johns Hopkins Wilmer Eye Institute, the… Read more »
Recent Comments